Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.71 CAD | +0.59% | +3.01% | -48.96% |
Sales 2024 * | - | Sales 2025 * | 1.04M 759K | Capitalization | 26.88M 19.57M |
---|---|---|---|---|---|
Net income 2024 * | -74M -53.89M | Net income 2025 * | -54M -39.32M | EV / Sales 2024 * | - |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 25.8 x |
P/E ratio 2024 * |
-0.25
x | P/E ratio 2025 * |
-0.35
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 80.93% |
Latest transcript on Aptose Biosciences Inc.
1 day | +0.59% | ||
1 week | +3.01% | ||
Current month | +1.18% | ||
1 month | -14.93% | ||
3 months | -37.82% | ||
6 months | -59.76% | ||
Current year | -48.96% |
Managers | Title | Age | Since |
---|---|---|---|
William Rice
CEO | Chief Executive Officer | 65 | 13-10-27 |
C. Payne
DFI | Director of Finance/CFO | 61 | 22-06-26 |
Chief Tech/Sci/R&D Officer | - | 19-10-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Denis Burger
BRD | Director/Board Member | 80 | 07-09-18 |
Bernd Seizinger
BRD | Director/Board Member | 67 | 22-09-12 |
Mark Vincent
BRD | Director/Board Member | 71 | 07-09-18 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-08 | 1.71 | +0.59% | 1,910 |
24-05-07 | 1.7 | +0.59% | 4,988 |
24-05-06 | 1.69 | +3.05% | 3,675 |
24-05-03 | 1.64 | -0.61% | 4,133 |
24-05-02 | 1.65 | -0.60% | 3,109 |
Delayed Quote Toronto S.E., May 08, 2024 at 03:56 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-48.96% | 19.59M | |
+22.56% | 46.71B | |
-1.51% | 41.52B | |
+48.83% | 41.8B | |
-3.42% | 29.55B | |
+10.13% | 25.78B | |
-20.44% | 19.26B | |
+26.45% | 11.98B | |
-0.14% | 12.14B | |
-0.47% | 12.08B |
- Stock Market
- Equities
- APS Stock